Related Experiment Video
Updated: Jun 17, 2026
04:22
Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
Published on: March 30, 2017
Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice
Rakhee Raghunandan1,2, Parisa Aslani3, Timothy F Chen3
1Leeder Centre for Health Policy, Economics and Data, School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2006, Australia. rakhee.raghunandan@sydney.edu.au.
Pharmacoeconomics
|June 16, 2026
Summary
Community pharmacists prefer dose administration aid (DAA) services with better government funding and no caps. Inadequate reimbursement and service limits are key barriers to DAA provision.
Area of Science:
- Pharmacy Practice
- Health Services Research
- Medication Management
Background:
- Dose administration aids (DAAs) are crucial for medication adherence.
- Little is known about community pharmacists' perceptions of DAA benefits and challenges.
- Understanding pharmacist preferences is key to optimizing DAA service delivery.
Purpose of the Study:
- To explore community pharmacists' preferences for DAA service attributes.
- To identify factors influencing pharmacists' decisions to provide DAA services.
Main Methods:
- A discrete choice experiment (DCE) surveyed 615 community pharmacists.
- Participants evaluated 12 choice scenarios comparing DAA services with no service.
- Key attributes included funding, staff time, and service caps.
Main Results:
- Pharmacists favored services with higher government reimbursement.
- Increased staff time and caps on funded services reduced likelihood of provision.
- Patient type and co-payment did not significantly influence preferences.
Conclusions:
- Inadequate government reimbursement and service caps are major barriers to DAA provision.
- Findings inform the redesign of sustainable and equitable community pharmacy DAA services.
- Understanding pharmacist preferences is vital for successful DAA implementation.
Related Concept Videos
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:29Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...